Cargando…

Design, Synthesis, and Evaluation of Dihydropyranopyrazole Derivatives as Novel PDE2 Inhibitors for the Treatment of Alzheimer’s Disease

Phosphodiesterase 2 (PDE2) has been regarded as a novel target for the treatment of Alzheimer’s disease (AD). In this study, we obtained (R)-LZ77 as a hit compound with moderate PDE2 inhibitory activity (IC(50) = 261.3 nM) using a high-throughput virtual screening method based on molecular dynamics....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yan, Li, Jinjian, Yuan, Han, Su, Rui, Huang, Yue, Huang, Yiyou, Li, Zhe, Wu, Yinuo, Luo, Haibin, Zhang, Chen, Huang, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160813/ https://www.ncbi.nlm.nih.gov/pubmed/34069639 http://dx.doi.org/10.3390/molecules26103034

Ejemplares similares

Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors
por: Wu, Xu-Nian, et al.
Publicado: (2018)

Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer’s disease
por: Su, Tao, et al.
Publicado: (2016)

Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer’s disease
por: Zhang, Chen, et al.
Publicado: (2017)

Structure-Based Design, Synthesis, Biological Evaluation, and Molecular Docking of Novel PDE10 Inhibitors With Antioxidant Activities
por: Li, Jinxuan, et al.
Publicado: (2018)

Design and Microwave Assisted Synthesis of Coumarin Derivatives as PDE Inhibitors
por: Kumbar, Mahadev N., et al.
Publicado: (2016)

Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia
por: Wu, Xu-Nian, et al.
Publicado: (2022)

Design, Synthesis and Evaluation of Hesperetin Derivatives as Potential Multifunctional Anti-Alzheimer Agents
por: Li, Bo, et al.
Publicado: (2017)

The anti-depressant effects of a novel PDE4 inhibitor derived from resveratrol
por: Yu, Yingcong, et al.
Publicado: (2021)

Phosphodiesterase (PDE)-4 Inhibitors and COPD Correlation with Cancer
por: Organtzis, John, et al.
Publicado: (2014)

Computational Study on Selective PDE9 Inhibitors on PDE9-Mg/Mg, PDE9-Zn/Mg, and PDE9-Zn/Zn Systems
por: Sivakumar, Dakshinamurthy, et al.
Publicado: (2021)

Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
por: Szczypka, Marianna
Publicado: (2020)

Treating COPD with PDE 4 inhibitors
por: Brown, William M
Publicado: (2007)

Identification of pyrazolopyridazinones as PDEδ inhibitors
por: Papke, Björn, et al.
Publicado: (2016)

Synthesis and Modeling Studies of Furoxan Coupled Spiro-Isoquinolino Piperidine Derivatives as NO Releasing PDE 5 Inhibitors
por: Prabhuling, Swami, et al.
Publicado: (2020)

Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer’s Diseases
por: Guo, Yan, et al.
Publicado: (2020)

Central serous chorioretinopathy treatment with a systemic PDE5 and PDE6 inhibitor (sildenafil)
por: Coleman, D. Jackson, et al.
Publicado: (2020)

Activation of PDE10 and PDE11
por: Jäger, Ronald, et al.
Publicado: (2011)

The efficacy of PDE5 inhibitors in diabetic patients
por: Swiecicka, Agnieszka
Publicado: (2022)

PDE5 inhibitor drugs for use in dementia
por: Hainsworth, Atticus H., et al.
Publicado: (2023)

Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer’s disease
por: Lan, Jin-Shuai, et al.
Publicado: (2017)

Novel PDE4 Inhibitors Derived from Chinese Medicine Forsythia
por: Coon, Tiffany A., et al.
Publicado: (2014)

Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development
por: Kayık, Gülru, et al.
Publicado: (2017)

A Yeast-Based Chemical Screen Identifies a PDE Inhibitor That Elevates Steroidogenesis in Mouse Leydig Cells via PDE8 and PDE4 Inhibition
por: Demirbas, Didem, et al.
Publicado: (2013)

Comparison of the Pharmacological Profiles of Selective PDE4B and PDE4D Inhibitors in the Central Nervous System
por: Zhang, Chong, et al.
Publicado: (2017)

Treatment Strategy for Non-Responders to PDE5 Inhibitors
por: Park, Nam Cheol, et al.
Publicado: (2013)

AB041. Evolution of PDE5 inhibitors in Korea
por: Moon, Du Geon
Publicado: (2015)

PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib]
por: Booth, Laurence, et al.
Publicado: (2017)

Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis
por: Yang, Xudan, et al.
Publicado: (2023)

Phosphodiesterase Type 5 (PDE5) Inhibitors Sensitize Topoisomerase II Inhibitors in Killing Prostate Cancer Through PDE5-Independent Impairment of HR and NHEJ DNA Repair Systems
por: Chang, Jo-Fan, et al.
Publicado: (2019)

Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis
por: Park, Sung-Jun, et al.
Publicado: (2021)

Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A
por: Alexander, M S, et al.
Publicado: (2016)

Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review
por: Blauvelt, Andrew, et al.
Publicado: (2023)

Rolipram, a PDE4 Inhibitor, Enhances the Inotropic Effect of Rat Heart by Activating SERCA2a
por: Huang, Huili, et al.
Publicado: (2019)

Design, synthesis, and biological evaluation of novel triazoloquinazolinone derivatives as SHP2 protein inhibitors
por: Luo, Rongshuang, et al.
Publicado: (2021)

Correction to: Zhang et al., Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer’s disease
Publicado: (2018)

PDE6D Inhibitors with a New Design Principle Selectively Block K-Ras Activity
por: Siddiqui, Farid A., et al.
Publicado: (2019)

Design and Synthesis of Potent N-Acylethanolamine-hydrolyzing Acid Amidase (NAAA) Inhibitor as Anti-Inflammatory Compounds
por: Li, Yuhang, et al.
Publicado: (2012)

Modulation of oxazolone-induced hypersensitivity in mice by selective PDE inhibitors
por: Moodley, I., et al.
Publicado: (1995)

PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis
por: Noel, Sabrina, et al.
Publicado: (2012)

Using PDE5 inhibitors for the prevention and treatment of colorectal cancer
por: Browning, Darren D
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_62tesbgalkligs08ngdi4ub2qq